Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. There are facilities ([[public]] and [[private]]) that can perform comprehensive genetic testing (genetic panels) on tumor [[specimen]]s to characterize the above entities and more, e.g. the Genomics Research Core at the University of Pittsburgh, or FoundationOne CDx. Brain-specific profiles are also marketed, e.g. NeoTYPE Brain Tumor Profile by NeoGenomics, Fort Myers, Florida, which includes: [[ATRX]], [[BRAF]], [[EGFR]], [[IDH1]], [[IDH2]], [[MGMT]] Promoter Methylation analysis (PCR), [[PTEN]], [[TERT]] Promoter, [[TP53]], [[1p/19q co-deletion]], and many others. Cost is on the order of $2000–4000U.S., turnaround time ≈ 2 weeks. tumor_specimen.txt Last modified: 2024/06/07 02:59by 127.0.0.1